A5053732969- Advances in Oncology and Radiotherapy
- Lysosomal Storage Disorders Research
- Virus-based gene therapy research
- Advanced Radiotherapy Techniques
- CRISPR and Genetic Engineering
- Economic and Financial Impacts of Cancer
- Biomedical Research and Pathophysiology
- Primary Care and Health Outcomes
- Health and Medical Research Impacts
- Patient-Provider Communication in Healthcare
- Animal Genetics and Reproduction
- Lung Cancer Diagnosis and Treatment
- Radiomics and Machine Learning in Medical Imaging
- Palliative Care and End-of-Life Issues
- Ethics in Clinical Research
- Frailty in Older Adults
- Health Systems, Economic Evaluations, Quality of Life
- CAR-T cell therapy research
- Cerebrospinal fluid and hydrocephalus
University of Manchester
2024-2025
Henry Royce Institute
2024
The Christie NHS Foundation Trust
2024
Abstract An emerging approach to complement randomised controlled trial (RCT) data in the development of radiotherapy treatments is use routinely collected ‘real-world’ (RWD). RWD as standard-of-care about all patients during their usual cancer care pathway. Given nature this data, important questions remain permissibility and acceptability using routine practice. We involved engaged with patients, carers public a two-day citizens’ jury understand views obtain decisions regarding two key...
Hematopoietic stem cell gene therapy (HSCGT) is a promising therapeutic strategy for the treatment of neurodegenerative, metabolic disorders. The approach involves
Pragmatic methodologies, often termed rapid-learning, are being pursued that can match the pace of innovation in radiotherapy and generate evidence from real-world treatment setting. It is important to understand feasibility implementing such pragmatic approaches before their application practice. This study investigated key professional stakeholders' perceptions opinions rapid-learning data (RWD). Twenty-three interviews were conducted with stakeholders based across five UK cancer centres....